Daily Archives: October 3, 2022
AAP Clinical Report | Controlling and treating head lice in children and adolescents.
3 Oct, 2022 | 14:04h | UTC
AAP Recommendations | Prevention of pediatric all-terrain vehicles related deaths and injuries.
3 Oct, 2022 | 14:05h | UTCTechnical Report: A Comprehensive Report on All-Terrain Vehicles and Youth: Continuing Challenges for Injury Prevention – Pediatrics
Commentaries:
ATVs Are Not Safe for Children: AAP Policy Explained – Health Children
AAP Calls for Prevention of Pediatric ATV-Linked Deaths, Injuries – HealthDay
AAP Clinical Report | Evaluation for bleeding disorders in suspected child abuse.
3 Oct, 2022 | 14:03h | UTCEvaluation for Bleeding Disorders in Suspected Child Abuse – Pediatrics’
Technical Report: Evaluating for Suspected Child Abuse: Conditions That Predispose to Bleeding – American Academy of Pediatrics
Commentary: AAP guidance helps distinguish bleeding disorders from abuse – MDedge
Consensus Recommendations | Priority activities to address acute kidney injury in children.
3 Oct, 2022 | 14:01h | UTCInvited Commentary: Highlights of Consensus-Based Recommendations for Acute Kidney Injury in Children – JAMA Network Open
Commentary on Twitter
Pediatric ADQI consensus statement describes the current state and future research, educational, & advocacy work to improve awareness of acute kidney injury in children and young adults, advance diagnostics, and move the needle for management. #OAResearch https://t.co/Qph7tSqicv
— JAMA Network Open (@JAMANetworkOpen) September 30, 2022
Cohort Study | Diabetes diagnosed at younger ages is associated with increased morbidity compared to diagnosis in older adults.
3 Oct, 2022 | 14:02h | UTC
M-A of randomized trials | Colchicine and coronary heart disease risks.
3 Oct, 2022 | 14:00h | UTCRelated:
Expert Analysis | Colchicine in acute coronary syndrome: when to commence?
Review: Colchicine and the heart.
M-A: Colchicine administration for percutaneous coronary intervention
M-A: Efficacy and safety of low-dose colchicine in patients with coronary disease
Meta-analysis: Colchicine reduces new cardiovascular events in patients with coronary artery disease
Expert analysis: Efficacy and safety of colchicine in patients with chronic stable coronary disease
#ESCCongress – Randomized trial: Colchicine not beneficial for patients with acute coronary syndrome
Research: Colchicine Therapy and Plaque Stabilization in Patients With Acute Coronary Syndrome
Guideline | Operative management of acute abdomen after bariatric surgery in the emergency setting.
3 Oct, 2022 | 13:59h | UTC
Brief review | Optimal sedation strategy for critically ill patients.
3 Oct, 2022 | 13:56h | UTC
Long-term follow-up of a RCT | P2Y12 inhibitor monotherapy vs. DAPT after percutaneous coronary intervention.
3 Oct, 2022 | 13:58h | UTCLong-term Effects of P2Y12 Inhibitor Monotherapy After Percutaneous Coronary Intervention: 3-Year Follow-up of the SMART-CHOICE Randomized Clinical Trial – JAMA Cardiology (link to abstract – $ for full-text)
Original Study: Randomized Trials: Shorter Duration of Dual Antiplatelet Therapy May be an Option for Patients Undergoing Percutaneous Coronary Intervention
Commentary on Twitter
In #RCT follow-up, P2Y12 inhibitor monotherapy after 3 months of DAPT found to be comparable with prolonged DAPT for preventing ischemic events. P2Y12 inhibitor monotherapy resulted in significantly lower rate of major bleeding for up to 3 yrs. https://t.co/pBv9X87lEg #Research pic.twitter.com/42Y28hPPT2
— JAMA Cardiology (@JAMACardio) September 30, 2022
RCT | A behavioral intervention delivered by text messages did not reduce sexually transmitted reinfections in young people.
3 Oct, 2022 | 13:57h | UTCNews Release: Texting young people about safe sex does not reduce STI reinfection – BMJ Newsroom
Commentary on Twitter
New research: Sending regular texts to young people who have recently had a sexually transmitted infection (#STI) to encourage #safesex does not reduce rates of chlamydia and gonorrhoea reinfection, finds a trial published by @bmj_latest today.https://t.co/OgQqPAsbS7 pic.twitter.com/0QTLqPuzDX
— BMJ (@bmj_company) September 29, 2022
Review | Acute kidney injury in patients with liver disease.
3 Oct, 2022 | 13:56h | UTC
Commentary on Twitter
AKI is commonly encountered in patients with decompensated cirrhosis, and it is associated with unfavorable outcomes. This article discusses tailoring management of AKI in patients with liver disease to the specific underlying etiology https://t.co/UVEeYBL8ff@VelezNephHepato pic.twitter.com/V5J8hBQyuw
— CJASN (@CJASN) September 27, 2022
RCT | Analgesic efficacy of intravenous dexamethasone as an adjunct to paravertebral block in thoracoscopic surgery.
3 Oct, 2022 | 13:54h | UTC
Brief Review | Pregnancy-related acute kidney injury: do we know what to do?
3 Oct, 2022 | 13:54h | UTCPregnancy-Related Acute Kidney Injury: Do We Know What to Do? – Nephron
RCT | Antibiotic prophylaxis vs. no prophylaxis in breast cancer surgery.
3 Oct, 2022 | 13:47h | UTCAntibiotic prophylaxis in breast cancer surgery (PAUS trial): randomised clinical double-blind parallel-group multicentre superiority trial – British Journal of Surgery (link to abstract – $ for full-text)
Systematic Review | Physical activity and exercise training in cystic fibrosis.
3 Oct, 2022 | 13:46h | UTCPhysical activity and exercise training in cystic fibrosis – Cochrane Library
Summary: Physical activity to improve exercise capacity in people with cystic fibrosis – Cochrane Library
Commentary on Twitter
??♂️?️♂️?♂️ People with #cysticfibrosis probably benefit from physical activity interventions for six months: evidence from a recent #Cochrane review ➡️https://t.co/T3JyBm6bSd@CochraneLibrary @CochraneNursing #CochraneHongKong #SystematicReview #cuhknursing #exercise pic.twitter.com/evzTm7Xpo9
— Cochrane Nursing (@CochraneNursing) August 24, 2022
Systematic Review | Repetitive peripheral magnetic stimulation after stroke – not enough evidence to guide recommendations.
3 Oct, 2022 | 13:45h | UTC
Cochrane Library | Preoperative exercise training for people with non‐small cell lung cancer.
3 Oct, 2022 | 13:44h | UTCPreoperative exercise training for people with non‐small cell lung cancer – Cochrane Library
RCT | Selumetinib plus adjuvant radioactive iodine in patients with high-risk differentiated thyroid cancer.
3 Oct, 2022 | 13:42h | UTCCommentary: Selumetinib Does Not Improve CR Rate in Differentiated Thyroid Cancer – Cancer Therapy Adviser
Commentary on Twitter
❎ ASTRA trial: Radioactive iodine ± selumetinib doesn't improve remission rates for high-risk #thyroidcancer
✅ Postoperative pathologic risk stratification identified pts at risk of primary treatment failurehttps://t.co/kvakaMXtDh#JCO #thycsm @MSKCancerCenter pic.twitter.com/mvQwgzIjWh— Journal of Clinical Oncology (@JCO_ASCO) March 16, 2022